Karen Knudsen: We are grateful to President Biden for his continued commitment to ending cancer

Karen Knudsen shared a post by Lisa Lacasse, adding:

“The Cancer Moonshot is a critical step in prioritizing investment in cancer research and helping reduce the cancer burden.

We are grateful to President Biden for his continued commitment to ending cancer as we know it, for everyone.”

Quoting Lisa Lacasse’s post:

“Families affected by cancer are grateful to President Biden for a continued commitment to make reducing the cancer burden a national priority.

American Cancer Society Cancer Action Network (ACS CAN) remains committed to our shared priority with President Biden to end cancer as we know it, for everyone.”

Sources: Karen Knudsen/X and Lisa Lacasse/X

Karen E. Knudsen, MBA PhD, is the CEO of both the American Cancer Society (ACS) and the American Cancer Society Cancer Action Network (ACS CAN). She leads these organizations with a tripartite strategy focused on discovery, advocacy, and patient support, making ACS the largest non-profit funder of cancer research outside the US government.

Dr. Knudsen is known for her practice-changing research in prostate cancer, which has contributed to new, effective cancer treatments. She also holds several thought leadership roles, including advisory positions with the National Cancer Institute and the American Society for Clinical Oncology.

Lisa Lacasse, President of the American Cancer Society Cancer Action Network (ACS CAN), has an impactful leadership in healthcare advocacy. Leading ACS CAN’s nationwide public policy advocacy agenda with her oversight of a dedicated team in Washington, D.C., she ensures effective advocacy efforts at the highest levels.

Beyond her role at ACS CAN, Lacasse’s commitment to public health extends to serving on the board for the Campaign for Tobacco-Free Kids. Her approach and dedication continue to drive positive change in the fight against cancer and tobacco-related diseases.